Israeli pharmaceutical company BiolineRX Ltd. reports a successful pretrial of its BL-8020 drug, which is designed to orally treat Hepatitis C. The company has announced that due to the success of the pretrial, it will launch human trials during the first quarter of 2013.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments